Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |